The Regents of the University of Colorado, a Body Corporate; A California Corporation;The Regents of the University of California, A California Corporation;The Regents of the University of California
发明人:
Bennett, Jeffrey L.,Owens, Gregory P.,Verkman, Alan S.
申请号：
AU2012245205
公开号：
AU2012245205B2
申请日:
2012.04.23
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention is directed to antibodies binding to aquaporin 4 (AQP4) and methods of using such antibodies to treat neuromyelitis optica (NMO) either as a monotherapy or in combination with standard NMO therapies such as immunosuppressives or plasmaphersis.
